Dianthus Therapeutics (DNTH) Other Gross PP&E Adjustments (2017 - 2025)
Dianthus Therapeutics has reported Other Gross PP&E Adjustments over the past 7 years, most recently at -$844000.0 for Q3 2025.
- Quarterly results put Other Gross PP&E Adjustments at -$844000.0 for Q3 2025, down 21200.0% from a year ago — trailing twelve months through Sep 2025 was -$844000.0 (down 21200.0% YoY), and the annual figure for FY2024 was -$10.3 million, down 51.83%.
- Other Gross PP&E Adjustments for Q3 2025 was -$844000.0 at Dianthus Therapeutics, up from -$921000.0 in the prior quarter.
- Over the last five years, Other Gross PP&E Adjustments for DNTH hit a ceiling of $4000.0 in Q3 2024 and a floor of -$25.4 million in Q1 2022.
- Median Other Gross PP&E Adjustments over the past 4 years was -$1.0 million (2025), compared with a mean of -$6.6 million.
- Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 100.94% in 2024 and later crashed 21200.0% in 2025.
- Dianthus Therapeutics' Other Gross PP&E Adjustments stood at -$915000.0 in 2022, then crashed by 642.62% to -$6.8 million in 2023, then plummeted by 51.83% to -$10.3 million in 2024, then skyrocketed by 91.82% to -$844000.0 in 2025.
- The last three reported values for Other Gross PP&E Adjustments were -$844000.0 (Q3 2025), -$921000.0 (Q2 2025), and -$1.0 million (Q1 2025) per Business Quant data.